PTC治疗 PTCT 深 沪
等待开盘 11-26 09:30:00 美东时间
82.93
+3.100
+3.88%
华盛通- 最 高85.615
- 今 开84.69
- 成交量 428.85万股
- 最 低 81.89
- 昨 收 79.83
- 总市值 65.88亿
- 52周最高 85.615
- 市盈率 静 --
- 换手率 5.40%
- 52周最低 35.95
- 委 比 24.23%
- 总股本 7943.81万
- 历史最高 85.615
- 量 比 3.58
- 振 幅 4.67%
- 历史最低 4.03
- 每 手 1
- 风险率 8.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Sandisk Shares Are Rallying Monday After Close
Sandisk is joining the S&P 500 Index, prompting a boost in the share price Monday after market close.
11-25 06:59
S&P Small Cap 600 Constituent Sandisk Corp. Will Replace The Interpublic Group Of Companies Inc. In The S&P 500, And PTC Therapeutics Inc. Will Replace Sandisk In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Friday, November 28
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251124-1480959/1480959_ipg-pinc-hbi-56.pdf
11-25 06:22
PTC Therapeutics to Host R&D Day
Event to take place on Dec. 2, 2025 in New York City WARREN, N.J., Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&D Day to discuss...
11-20 21:00
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
PTC Therapeutics (PTCT) Gets a Buy from Truist Financial
Truist Financial analyst Joon Lee maintained a Buy rating on PTC Therapeutics t...
11-05 20:57
PTC Therapeutics shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance.
PTC Therapeutics shares are trading higher after the company reported better-th...
11-05 05:45
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Analysts’ Top Healthcare Picks: Select Medical (SEM), PTC Therapeutics (PTCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
11-04 03:20
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Jefferies Maintains Buy on PTC Therapeutics, Raises Price Target to $77
Jefferies analyst Kelly Shi maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $63 to $77.
10-29 02:54
